Patient P-02607

Synthetic patientMETA-24 · Day 133 · 45–54 · M · baseline S15Steering view · 3D Open companion preview

Therapy response

Declining

Tolerance

Favorable

GI state

Favorable

Inflammatory state

Deteriorating

Nutritional resilience

Stable

Discontinuation risk

28%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S15
Day 29 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 29.

Primary contributors, last 14 days

Inflammatory activity+6
GI instability+4
Nutritional resilience-3
Treatment adherence-3
Toxicity-2

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

52 min

worsening · -7.1 vs previous 14 d

Sleep duration

Wearable

5.6 h

stable · -0.0 vs previous 14 d

Energy level

Daily log

4.6/10

worsening · -0.2 vs previous 14 d

Steps

Wearable

5,645

worsening · -648 vs previous 14 d

GI burden

Companion

26.8/100

worsening · +7.7 vs previous 14 d

Adherence

Companion

85.2 %

worsening · -4.5 vs previous 14 d

Sleep quality

Wearable

31.1/100

worsening · -3.7 vs previous 14 d

Glucose, CGM daily mean

CGM

139 mg/dL

stable · +3.1 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 63 from the failing basin, 26 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -4.2 next day on high-intake days · n 20

Would not help

Keep caffeine low
GI +4.7 next day on high-intake days · n 20

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Caffeine
+4.7detractor · 95%
Protein
-4.2supporter · 95%
Alcohol
+1.9no signal · 43%
Insoluble fibre
-1.2no signal · 23%
Dietary fat load
+0.9no signal · 23%
Histamine load
-0.7no signal · 15%
Ultra-processed food
-0.4no signal · 15%
Simple carbohydrates
-0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
Autonomic recovery ↓20
- WearableShort sleep window
Mucosal barrier integrity ↓10
- WearableSleep 5.6 h, below personal baseline

DNA

Fictional pharmacogenomic panel

CYP2D6 Poor metabolizer
Higher exposure at standard dose

Microbiome

Shannon diversity 4.5 · butyrate capacity 82/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisNormal
Bifidobacterium longumNormal
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 61 ms
Sleep: 5.7 h
Steps: 5,207
Resting HR: 59 bpm

Daily log: GI score 27, nutritional resilience 57, adherence 85.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02031	31%	S12	AD-05	improved	47
P-02285	30%	S14	AD-05	no change	39
P-02483	47%	S06	BR-03	no change	64
P-02280	33%	S07	BR-03	no change	50
P-02087	31%	S01	BR-03	no change	40
P-02522	31%	S01	BR-03	no change	40
P-02267	30%	S09	BR-03	no change	45
P-02354	31%	S01	CR-01	improved	78
P-02154	30%	S16	CR-01	improved	57
P-02233	30%	S16	CR-01	improved	66
P-02462	43%	S12	DT-01	improved	65
P-02491	42%	S09	DT-01	no change	65